Trials / Completed
CompletedNCT02118077
Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer
A Prospective, Randomized, Double-blind, Placebo-controlled, Group Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Cancer Advances Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare the effect of G17DT with that of placebo on the survival of subjects with advanced pancreatic cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | G17DT |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2004-04-01
- First posted
- 2014-04-21
- Last updated
- 2014-04-21
Source: ClinicalTrials.gov record NCT02118077. Inclusion in this directory is not an endorsement.